Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Conventional versus automated implantation of loose seeds in prostate brachytherapy: analysis of dosimetric and clinical results. In regard to Genebes et al.
Moerland MA, Maenhout M, van der Voort van Zyp JR, Noteboom JL, Eppinga WS, van Vulpen M, Monninkhof EM, Verkooijen HM. Moerland MA, et al. Among authors: van der voort van zyp jr, van vulpen m. Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):436-7. doi: 10.1016/j.ijrobp.2014.02.020. Epub 2014 May 5. Int J Radiat Oncol Biol Phys. 2014. PMID: 24837898 No abstract available.
Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life.
Peters M, Maenhout M, van der Voort van Zyp JR, Moerland MA, Moman MR, Steuten LM, van Deursen MJ, van Vulpen M. Peters M, et al. Among authors: van deursen mj, van der voort van zyp jr, van vulpen m. Radiother Oncol. 2014 Jul;112(1):77-82. doi: 10.1016/j.radonc.2014.06.013. Epub 2014 Jul 3. Radiother Oncol. 2014. PMID: 24998704
Rectal dose constraints for salvage iodine-125 prostate brachytherapy.
Peters M, Hoekstra CJ, van der Voort van Zyp JR, Westendorp H, van de Pol SM, Moerland MA, Maenhout M, Kattevilder R, van Vulpen M. Peters M, et al. Among authors: van de pol sm, van der voort van zyp jr, van vulpen m. Brachytherapy. 2016 Jan-Feb;15(1):85-93. doi: 10.1016/j.brachy.2015.10.004. Epub 2015 Nov 21. Brachytherapy. 2016. PMID: 26614233
Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapy.
Peters M, van der Voort van Zyp JR, Moerland MA, Hoekstra CJ, van de Pol S, Westendorp H, Maenhout M, Kattevilder R, Verkooijen HM, van Rossum PS, Ahmed HU, Shah TT, Emberton M, van Vulpen M. Peters M, et al. Among authors: van rossum ps, van de pol s, van der voort van zyp jr, van vulpen m. Radiother Oncol. 2016 Apr;119(1):104-10. doi: 10.1016/j.radonc.2016.02.002. Epub 2016 Feb 17. Radiother Oncol. 2016. PMID: 26897512 Free article.
Development and internal validation of a multivariable prediction model for biochemical failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancer.
Peters M, van der Voort van Zyp JRN, Moerland MA, Hoekstra CJ, van de Pol S, Westendorp H, Maenhout M, Kattevilder R, Verkooijen HM, van Rossum PSN, Ahmed HU, Shah TT, Emberton M, van Vulpen M. Peters M, et al. Brachytherapy. 2016 May-Jun;15(3):296-305. doi: 10.1016/j.brachy.2016.01.004. Epub 2016 Mar 2. Brachytherapy. 2016. PMID: 26948662
PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure.
Shah TT, Peters M, Kanthabalan A, McCartan N, Fatola Y, van der Voort van Zyp J, van Vulpen M, Freeman A, Moore CM, Arya M, Emberton M, Ahmed HU. Shah TT, et al. Prostate Cancer Prostatic Dis. 2016 Sep;19(3):311-6. doi: 10.1038/pcan.2016.23. Epub 2016 Jul 19. Prostate Cancer Prostatic Dis. 2016. PMID: 27431499 Free PMC article.
98 results